150 related articles for article (PubMed ID: 7544718)
1. Serous effusion cytology in gynecologic malignant mixed müllerian tumors.
Modzelewski JR; Silverman JF; Berns LA; Sobieski MW; Finley JL
Diagn Cytopathol; 1995 Jun; 12(4):309-12. PubMed ID: 7544718
[TBL] [Abstract][Full Text] [Related]
2. Malignant mixed mullerian tumor in a rabbit (Oryctolagus cuniculus): case report with immunohistochemistry.
Goto M; Nomura Y; Une Y; Goldschmidt MH
Vet Pathol; 2006 Jul; 43(4):560-4. PubMed ID: 16847001
[TBL] [Abstract][Full Text] [Related]
3. Primary malignant mixed Müllerian tumor (metaplastic carcinoma) of the female peritoneum. A clinical, pathologic, and immunohistochemical study of three cases and a review of the literature.
Garamvoelgyi E; Guillou L; Gebhard S; Salmeron M; Seematter RJ; Hadji MH
Cancer; 1994 Aug; 74(3):854-63. PubMed ID: 7518735
[TBL] [Abstract][Full Text] [Related]
4. Carcinoma (malignant mixed müllerian [mesodermal] tumor) of the uterus and ovary. Correlation of clinical, pathologic, and immunohistochemical features in 29 cases.
Costa MJ; Khan R; Judd R
Arch Pathol Lab Med; 1991 Jun; 115(6):583-90. PubMed ID: 1710102
[TBL] [Abstract][Full Text] [Related]
5. CD34 immunohistochemistry in female genital tract carcinosarcoma (malignant mixed müllerian tumors) supports a dominant role of the carcinomatous component.
Costa MJ; Guinee D
Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):293-9. PubMed ID: 11127921
[TBL] [Abstract][Full Text] [Related]
6. Ascitic fluid cytology of a malignant mixed Müllerian tumor of the peritoneum: a report of two cases with special reference to p53 status.
Kato N; Motoyama T
Diagn Cytopathol; 2009 Apr; 37(4):281-5. PubMed ID: 19217035
[TBL] [Abstract][Full Text] [Related]
7. Malignant mixed müllerian tumors of the ovary.
Wei CF; Hwang SH; Ho CM; Shih BY; Chien TY
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Apr; 63(4):344-8. PubMed ID: 10820916
[TBL] [Abstract][Full Text] [Related]
8. Malignant mixed müllerian tumor of the uterus. Features favoring its origin from a common cell clone and an epithelial-to-mesenchymal transformation mechanism of histogenesis.
Guarino M; Giordano F; Pallotti F; Polizzotti G; Tricomi P; Cristofori E
Tumori; 1998; 84(3):391-7. PubMed ID: 9678624
[TBL] [Abstract][Full Text] [Related]
9. Bilateral ovarian malignant mixed Mullerian tumor in a dog.
Antuofermo E; Cocco R; Borzacchiello G; Burrai GP; Meloni F; Bonelli P; Pirino S; Cossu-Rocca P; Bosincu L
Vet Pathol; 2009 May; 46(3):453-6. PubMed ID: 19176505
[TBL] [Abstract][Full Text] [Related]
10. Malignant mixed müllerian tumor of the ovary: report of a case and review of the literature.
Shy SW; Lee WH; Lee MS; Lee MC
Zhonghua Yi Xue Za Zhi (Taipei); 1993 Jun; 51(6):468-73. PubMed ID: 8281496
[TBL] [Abstract][Full Text] [Related]
11. Uterine heterologous malignant mixed Müllerian tumor in a dwarf rabbit (Oryctolagus cuniculus).
Zadravec M; Gombač M; Račnik J; Zorman Rojs O; Pogačnik M; Švara T
J Vet Diagn Invest; 2012 Mar; 24(2):418-22. PubMed ID: 22379058
[TBL] [Abstract][Full Text] [Related]
12. [Sarcomas of the uterus: immunohistochemical characterization and diagnosis].
Jiang ZM
Zhonghua Bing Li Xue Za Zhi; 1992 Dec; 21(6):336-8. PubMed ID: 1284388
[TBL] [Abstract][Full Text] [Related]
13. Wilms tumor 1/cytokeratin dual-color immunostaining reveals distinctive staining patterns in metastatic melanoma, metastatic carcinoma, and mesothelial cells in pleural fluids: an effective first-line test for the workup of malignant effusions.
Conner JR; Cibas ES; Hornick JL; Qian X
Cancer Cytopathol; 2014 Aug; 122(8):586-95. PubMed ID: 25044880
[TBL] [Abstract][Full Text] [Related]
14. Cervical and peritoneal fluid cytology of uterine sarcomas.
Wang X; Khoo US; Xue WC; Cheung AN
Acta Cytol; 2002; 46(3):465-9. PubMed ID: 12040638
[TBL] [Abstract][Full Text] [Related]
15. Eight cases of malignant mixed Müllerian tumor (carcinosarcoma) of the uterus: findings in SurePath™ cervical cytology.
Gupta N; Dudding N; Smith JH
Diagn Cytopathol; 2014 Feb; 42(2):165-9. PubMed ID: 22865798
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD10 in malignant müllerian mixed tumors and adenosarcomas: an immunohistochemical study.
Mikami Y; Hata S; Kiyokawa T; Manabe T
Mod Pathol; 2002 Sep; 15(9):923-30. PubMed ID: 12218209
[TBL] [Abstract][Full Text] [Related]
17. Extrauterine pelvic malignant mixed mesodermal tumors. A study of 10 cases with immunohistochemistry.
Deligdisch L; Plaxe S; Cohen CJ
Int J Gynecol Pathol; 1988; 7(4):361-72. PubMed ID: 2466009
[TBL] [Abstract][Full Text] [Related]
18. Pax8: a marker for carcinoma of Müllerian origin in serous effusions.
Tong GX; Devaraj K; Hamele-Bena D; Yu WM; Turk A; Chen X; Wright JD; Greenebaum E
Diagn Cytopathol; 2011 Aug; 39(8):567-74. PubMed ID: 20607683
[TBL] [Abstract][Full Text] [Related]
19. Malignant mullerian mixed tumors of the uterine cervix: a report of nine cases of a neoplasm with morphology often different from its counterpart in the corpus.
Clement PB; Zubovits JT; Young RH; Scully RE
Int J Gynecol Pathol; 1998 Jul; 17(3):211-22. PubMed ID: 9656116
[TBL] [Abstract][Full Text] [Related]
20. Mullerian adenosarcomas: an immunophenotypic analysis of 35 cases.
Soslow RA; Ali A; Oliva E
Am J Surg Pathol; 2008 Jul; 32(7):1013-21. PubMed ID: 18469708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
